Mesenchymal stem cells are undifferentiated cells, which means they are not cells that form part of a tissue or organ, but they have the ability to become other types of cells, such as bone, cartilage, muscle, fat, and more. Due to their multiple capabilities, they can induce other cells to improve their functions, which gives them the ability to repair organs and tissues.
Mesenchymal stem cell therapy is part of a branch known as regenerative medicine, which promotes the repair and regeneration of tissues affected by disease or simply aging.
Any person aiming to improve their quality of life, regardless of whether they have a chronic-degenerative, autoimmune disease or are completely healthy. Currently, it is known that there are no contraindications for this therapy.
The method of application, quantity, and treatment protocol will be determined by the needs and expectations of each patient. We offer intravenous, intra-articular, and intradermal mesenchymal stem cell applications.
They can be used as adjuvant therapy in the treatment of heart, liver, lung, neurodegenerative, autoimmune, or rheumatological diseases, gastrointestinal conditions, type I and II diabetes, osteoarthritis. They are very useful in degenerative and autoimmune diseases, or even as prevention of future conditions or simply seeking a better quality of life in the long term.
No, but prior to the application, an evaluation consultation is carried out to gather the patient's medical information and determine the treatment to follow in a personalized way.
The number of sessions is determined during the evaluation consultation with our doctors, who will determine the number of applications, the quantity, and the time between them according to each patient's needs.
No complications have been reported. However, some side effects such as headaches, nausea, and tachycardia during the application and post-application can occur. These include fever, joint pain, nausea, fatigue, and headaches. All these are controllable and perfectly normal during the first 24 hours after the application. None of these put the patient at risk, and not all patients experience them.
At Cellstime Clinique, we only administer cells from the Lcells laboratory obtained from donor mothers' placentas, which undergo multiple tests to provide complete safety in their use. Lcells has extensive experience, certification, and recognition at both national and international levels in the banking, processing, and specialized cultivation of placental mesenchymal stem cells.
Mesenchymal stem cells derived from Lcells placentas undergo multiple tests to ensure they do not express any immunological markers. Furthermore, since they come from placentas, they have not been exposed to environmental factors that could generate any type of acquired rejection; therefore, the possibility of rejection is practically null.
